Global HER2 Antibodies Market Research Report 2024

Report ID: 1990969 | Published Date: Sep 2024 | No. of Page: 84 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Trastuzumab
        1.2.3 Lapatinib
        1.2.4 Ado-trastuzumab emtansine
        1.2.5 Pertuzumab
        1.2.6 Everolimus
    1.3 Market by Application
        1.3.1 Global HER2 Antibodies Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 E-commerce
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global HER2 Antibodies Market Perspective (2017-2028)
    2.2 HER2 Antibodies Growth Trends by Region
        2.2.1 HER2 Antibodies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 HER2 Antibodies Historic Market Size by Region (2017-2022)
        2.2.3 HER2 Antibodies Forecasted Market Size by Region (2023-2028)
    2.3 HER2 Antibodies Market Dynamics
        2.3.1 HER2 Antibodies Industry Trends
        2.3.2 HER2 Antibodies Market Drivers
        2.3.3 HER2 Antibodies Market Challenges
        2.3.4 HER2 Antibodies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top HER2 Antibodies Players by Revenue
        3.1.1 Global Top HER2 Antibodies Players by Revenue (2017-2022)
        3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2017-2022)
    3.2 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by HER2 Antibodies Revenue
    3.4 Global HER2 Antibodies Market Concentration Ratio
        3.4.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2021
    3.5 HER2 Antibodies Key Players Head office and Area Served
    3.6 Key Players HER2 Antibodies Product Solution and Service
    3.7 Date of Enter into HER2 Antibodies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibodies Breakdown Data by Type
    4.1 Global HER2 Antibodies Historic Market Size by Type (2017-2022)
    4.2 Global HER2 Antibodies Forecasted Market Size by Type (2023-2028)
5 HER2 Antibodies Breakdown Data by Application
    5.1 Global HER2 Antibodies Historic Market Size by Application (2017-2022)
    5.2 Global HER2 Antibodies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America HER2 Antibodies Market Size (2017-2028)
    6.2 North America HER2 Antibodies Market Size by Country (2017-2022)
    6.3 North America HER2 Antibodies Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe HER2 Antibodies Market Size (2017-2028)
    7.2 Europe HER2 Antibodies Market Size by Country (2017-2022)
    7.3 Europe HER2 Antibodies Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific HER2 Antibodies Market Size (2017-2028)
    8.2 Asia-Pacific HER2 Antibodies Market Size by Country (2017-2022)
    8.3 Asia-Pacific HER2 Antibodies Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America HER2 Antibodies Market Size (2017-2028)
    9.2 Latin America HER2 Antibodies Market Size by Country (2017-2022)
    9.3 Latin America HER2 Antibodies Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa HER2 Antibodies Market Size (2017-2028)
    10.2 Middle East & Africa HER2 Antibodies Market Size by Country (2017-2022)
    10.3 Middle East & Africa HER2 Antibodies Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis HER2 Antibodies Introduction
        11.1.4 Novartis Revenue in HER2 Antibodies Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer HER2 Antibodies Introduction
        11.2.4 Pfizer Revenue in HER2 Antibodies Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche HER2 Antibodies Introduction
        11.3.4 Roche Revenue in HER2 Antibodies Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Abnova
        11.4.1 Abnova Company Detail
        11.4.2 Abnova Business Overview
        11.4.3 Abnova HER2 Antibodies Introduction
        11.4.4 Abnova Revenue in HER2 Antibodies Business (2017-2022)
        11.4.5 Abnova Recent Development
    11.5 InvivoGen
        11.5.1 InvivoGen Company Detail
        11.5.2 InvivoGen Business Overview
        11.5.3 InvivoGen HER2 Antibodies Introduction
        11.5.4 InvivoGen Revenue in HER2 Antibodies Business (2017-2022)
        11.5.5 InvivoGen Recent Development
    11.6 Celltrion
        11.6.1 Celltrion Company Detail
        11.6.2 Celltrion Business Overview
        11.6.3 Celltrion HER2 Antibodies Introduction
        11.6.4 Celltrion Revenue in HER2 Antibodies Business (2017-2022)
        11.6.5 Celltrion Recent Development
    11.7 Biocon
        11.7.1 Biocon Company Detail
        11.7.2 Biocon Business Overview
        11.7.3 Biocon HER2 Antibodies Introduction
        11.7.4 Biocon Revenue in HER2 Antibodies Business (2017-2022)
        11.7.5 Biocon Recent Development
    11.8 Novus Biologicals
        11.8.1 Novus Biologicals Company Detail
        11.8.2 Novus Biologicals Business Overview
        11.8.3 Novus Biologicals HER2 Antibodies Introduction
        11.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2017-2022)
        11.8.5 Novus Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global HER2 Antibodies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Trastuzumab
    Table 3. Key Players of Lapatinib
    Table 4. Key Players of Ado-trastuzumab emtansine
    Table 5. Key Players of Pertuzumab
    Table 6. Key Players of Everolimus
    Table 7. Global HER2 Antibodies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global HER2 Antibodies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global HER2 Antibodies Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global HER2 Antibodies Market Share by Region (2017-2022)
    Table 11. Global HER2 Antibodies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global HER2 Antibodies Market Share by Region (2023-2028)
    Table 13. HER2 Antibodies Market Trends
    Table 14. HER2 Antibodies Market Drivers
    Table 15. HER2 Antibodies Market Challenges
    Table 16. HER2 Antibodies Market Restraints
    Table 17. Global HER2 Antibodies Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global HER2 Antibodies Market Share by Players (2017-2022)
    Table 19. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibodies as of 2021)
    Table 20. Ranking of Global Top HER2 Antibodies Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by HER2 Antibodies Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players HER2 Antibodies Product Solution and Service
    Table 24. Date of Enter into HER2 Antibodies Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global HER2 Antibodies Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global HER2 Antibodies Revenue Market Share by Type (2017-2022)
    Table 28. Global HER2 Antibodies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global HER2 Antibodies Revenue Market Share by Type (2023-2028)
    Table 30. Global HER2 Antibodies Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global HER2 Antibodies Revenue Market Share by Application (2017-2022)
    Table 32. Global HER2 Antibodies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global HER2 Antibodies Revenue Market Share by Application (2023-2028)
    Table 34. North America HER2 Antibodies Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America HER2 Antibodies Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe HER2 Antibodies Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe HER2 Antibodies Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific HER2 Antibodies Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific HER2 Antibodies Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America HER2 Antibodies Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America HER2 Antibodies Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa HER2 Antibodies Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa HER2 Antibodies Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Novartis Company Detail
    Table 45. Novartis Business Overview
    Table 46. Novartis HER2 Antibodies Product
    Table 47. Novartis Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 48. Novartis Recent Development
    Table 49. Pfizer Company Detail
    Table 50. Pfizer Business Overview
    Table 51. Pfizer HER2 Antibodies Product
    Table 52. Pfizer Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 53. Pfizer Recent Development
    Table 54. Roche Company Detail
    Table 55. Roche Business Overview
    Table 56. Roche HER2 Antibodies Product
    Table 57. Roche Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 58. Roche Recent Development
    Table 59. Abnova Company Detail
    Table 60. Abnova Business Overview
    Table 61. Abnova HER2 Antibodies Product
    Table 62. Abnova Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 63. Abnova Recent Development
    Table 64. InvivoGen Company Detail
    Table 65. InvivoGen Business Overview
    Table 66. InvivoGen HER2 Antibodies Product
    Table 67. InvivoGen Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 68. InvivoGen Recent Development
    Table 69. Celltrion Company Detail
    Table 70. Celltrion Business Overview
    Table 71. Celltrion HER2 Antibodies Product
    Table 72. Celltrion Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 73. Celltrion Recent Development
    Table 74. Biocon Company Detail
    Table 75. Biocon Business Overview
    Table 76. Biocon HER2 Antibodies Product
    Table 77. Biocon Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 78. Biocon Recent Development
    Table 79. Novus Biologicals Company Detail
    Table 80. Novus Biologicals Business Overview
    Table 81. Novus Biologicals HER2 Antibodies Product
    Table 82. Novus Biologicals Revenue in HER2 Antibodies Business (2017-2022) & (US$ Million)
    Table 83. Novus Biologicals Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HER2 Antibodies Market Share by Type: 2021 VS 2028
    Figure 2. Trastuzumab Features
    Figure 3. Lapatinib Features
    Figure 4. Ado-trastuzumab emtansine Features
    Figure 5. Pertuzumab Features
    Figure 6. Everolimus Features
    Figure 7. Global HER2 Antibodies Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. E-commerce Case Studies
    Figure 11. HER2 Antibodies Report Years Considered
    Figure 12. Global HER2 Antibodies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global HER2 Antibodies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global HER2 Antibodies Market Share by Region: 2021 VS 2028
    Figure 15. Global HER2 Antibodies Market Share by Players in 2021
    Figure 16. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibodies as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by HER2 Antibodies Revenue in 2021
    Figure 18. North America HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America HER2 Antibodies Market Share by Country (2017-2028)
    Figure 20. United States HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe HER2 Antibodies Market Share by Country (2017-2028)
    Figure 24. Germany HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific HER2 Antibodies Market Share by Region (2017-2028)
    Figure 32. China HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America HER2 Antibodies Market Share by Country (2017-2028)
    Figure 40. Mexico HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa HER2 Antibodies Market Share by Country (2017-2028)
    Figure 44. Turkey HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia HER2 Antibodies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Novartis Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 49. Abnova Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 50. InvivoGen Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 51. Celltrion Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 52. Biocon Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 53. Novus Biologicals Revenue Growth Rate in HER2 Antibodies Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Frequently Asked Questions
HER2 Antibodies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HER2 Antibodies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HER2 Antibodies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports